Two patients with Parkinson's disease received treatment with ropinirole an
d/or pramipexole, during which both experienced sleep attacks. These attack
s may be a class effect of non-ergot dopamine agonists. Health care profess
ionals should be aware of the potential of these agents to cause sleep atta
cks and caution patients about this potentially life-threatening adverse ef
fect.